US Device Guide

The Cardiac Interventions Today Europe Device Guide offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.


Featured Center



Current Supplement




DEFINE REAL Study Shows Impact of Routine Invasive Physiology on Treatment Strategies in Multivessel CAD

February 23, 2018 -- Results from the DEFINE REAL study were published by Eric Van Belle, MD, et al in Journal of the American College of Cardiology (JACC): Cardiovascular Int…

Cardiva Medical Receives Financing for Vascular Closure Systems

February 23, 2018 -- Cardiva Medical, Inc. announced that the company has closed on $11 million in additional financing to be used to continue United States commercial expansi…

One-Year Results Published for Abbott Vascular's Portico TAVR Device in Patients With Severe Aortic Stenosis

February 19, 2018 -- The 1-year results of an international multicenter study of the Portico transcatheter aortic valve replacement (TAVR) system (Abbott Vascular) were publis…

LivaNova Agrees to Acquire TandemLife

February 14, 2018 -- LivaNova PLC announced it has entered into an agreement to acquire TandemLife. TandemLife offers four product systems built around a common pump and contr…

Edwards' Self-Expanding Centera Valve Receives CE Mark

February 15, 2018 -- Edwards Lifesciences announced that its self-expanding Centera valve has received CE Mark approval. The Centera valve is indicated for the treatment of se…

Abiomed's Impella 2.5 and CP Heart Pumps Receive Expanded Indication for High-Risk PCI

February 14, 2018 -- Abiomed, Inc. announced its Impella 2.5 and Impella CP heart pump devices have received expanded US Food and Drug Administration (FDA) premarket approval …

Financing Will Support Commercialization of HeartFlow's FFRct Analysis Technology

February 14, 2018 -- HeartFlow, Inc. announced the closing of Series E financing, which secured $240 million that the company will use for commercial expansion of the company&…

Abiomed's Impella Devices Receive Expanded Indication for Cardiomyopathy With Cardiogenic Shock

February 13, 2018 -- Abiomed, Inc. announced that it has received an expanded US Food and Drug Administration (FDA) premarket approval for its Impella 2.5, Impella CP, Impella…

Lepu Medical's NeoVas Bioresorbable Scaffold Shown to Be Noninferior to Metallic Drug-Eluting Stents

February 12, 2018 -- Findings from a randomized controlled trial show that the NeoVas bioresorbable scaffold (BRS; Lepu Medical Technology (Beijing) Co., Ltd.) is noninferior …

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.